Applications of nanoparticle systems in drug delivery technology
By S. A. Rizvi, A. Saleh. Saudi Pharmaceutical Journal, 2017
1,109 citations recorded by the source corpus.
The development of nanoparticle-based drug formulations has yielded the opportunities to address and treat challenging diseases. Nanoparticles vary in size but are generally ranging from 100 to 500 nm. Through the manipulation of size, surface characteristics and material used, the nanoparticles can be developed into smart systems, encasing therapeutic and imaging agents as well as bearing stealth property. Further, these systems can deliver drug to specific tissues and provide controlled release therapy. This targeted and sustained drug delivery decreases the drug related toxicity and increase patient’s compliance with less frequent dosing. Nanotechnology has proven beneficial in the treatment of cancer, AIDS and many other disease, also providing advancement in diagnostic testing.
Subfields: Biomaterials, Biomedical Engineering, Pharmaceutical Science
View Paper: https://www.semanticscholar.org/paper/97ca7e363dfc4cb02b61242ea8e0e306c4f11c91
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- J. O. Ogbodo
- Evaristus Chinonso Odoh
- S. C. Eze
- Ugochukwu Solomon Okpala
- Charles Chinkwere Okoroafor
- Ugochukwu Gideon Nwadike
- C. P. Nwike
- Ufedo Lovet Onoja
Citations in the corpus
- Advances in drug delivery systems, challenges and future directions (2023, background): “These characteristics resulted in excellent tumor accumulation and less side effects, indicating that HA-DOX-CDDP micelles could be useful in breast cancer chemotherapy [53,54].”